MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
426.95%
Quick Ratio
426.95%
Cash Ratio
87.98%
Debt to Asset Ratio
16.32%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Intangible assets
    • Cash and cash equivalents
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Convertible preferred stock, 0.0...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
8,542
4,445
3,215
4,048
Short-term investments
32,105
-
-
-
Prepaid expenses and other current assets
806
1,008
1,111
1,126
Total current assets
41,453
5,453
4,326
5,174
Property and equipment, net
-
-
0
0
Goodwill
6,330
6,330
6,330
6,330
Intangible assets
13,500
13,500
13,500
42,200
Long-term investments
2,980
-
-
-
Other non-current assets
1,710
1,005
2
2
Total assets
65,973
26,288
24,158
53,706
Accounts payable
4,466
6,263
3,976
4,123
Accrued expenses and other current liabilities
1,542
2,451
2,204
1,621
Notes payable, net
-
4,923
-
-
Warrant liabilities
3,701
-
-
-
Total current liabilities
9,709
13,637
6,180
5,744
Deferred tax liability
1,060
1,060
1,060
1,772
Other long-term liability
-
-
0
0
Total liabilities
10,769
14,697
7,240
7,516
Convertible preferred stock, 0.001 par value, 5,000,000 shares authorized at june 30, 2026 and at december 31, 2025 24,610 shares issued and 12,232 shares outstanding at june 30, 2026 and at december 31, 2025
45,005
45,005
45,005
45,005
Common stock, 0.001 par value 100,000,000 shares authorized at june 30, 2026 and at december 31, 2025 85,767,032 shares and 27,550,222 shares issued and outstanding at june 30, 2026 and at december 31, 2025, respectively
172
114
113
111
Additional paid-in capital
423,580
373,643
373,133
370,422
Accumulated other comprehensive loss
-69
-62
-62
-44
Accumulated deficit
-413,484
-407,109
-401,271
-369,304
Total liabilities, convertible preferred stock and stockholders' equity
65,973
26,288
24,158
53,706
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$32,105K Cash and cashequivalents$8,542K (49.28%↑ Y/Y)Prepaid expenses andother current assets$806K (-8.41%↓ Y/Y)Total current assets$41,453K (527.89%↑ Y/Y)Intangible assets$13,500K (-68.01%↓ Y/Y)Goodwill$6,330K (0.00%↑ Y/Y)Long-term investments$2,980K Other non-currentassets$1,710K (-27.11%↓ Y/Y)Total assets$65,973K (14.78%↑ Y/Y)Total liabilities,convertible preferred stock...$65,973K (14.78%↑ Y/Y)Accumulated deficit-$413,484K (-13.68%↓ Y/Y)Accumulated othercomprehensive loss-$69K (-56.82%↓ Y/Y)Additional paid-in capital$423,580K (15.53%↑ Y/Y)Convertible preferredstock, 0.001 par value,...$45,005K (0.00%↑ Y/Y)Total liabilities$10,769K (13.77%↑ Y/Y)Common stock, 0.001 parvalue 100,000,000...$172K (57.80%↑ Y/Y)Total currentliabilities$9,709K (26.19%↑ Y/Y)Deferred tax liability$1,060K (-40.18%↓ Y/Y)Accounts payable$4,466K (-25.91%↓ Y/Y)Warrant liabilities$3,701K Accrued expenses andother current...$1,542K (-7.44%↓ Y/Y)

Rein Therapeutics, Inc. (RNTX)

Rein Therapeutics, Inc. (RNTX)